Todays GLP-1 drugs do a hundred different things, and we barely understand how or why
What to Expect in Months 4-6 Minimal side effects: 85%+ patients report little to no symptoms Fastest weight loss period: Average loss 15-18% by week 24 Appetite suppression as primary effect: Not unpleasant, just not hungry Metabolic improvements: Blood pressure drops, triglycerides down 28%, A1C down 1.8% in diabetics Increased confidence and motivation: Visible results, compliments from others, clothes fitting differently Data from Diabetes Care journal shows this acceleration phase is when cardiovascular benefits become measurable, blood pressure improvements, lipid improvements, reduced inflammation markers
GLP-1 comes in various forms, including daily injections and weekly injections
NSL literature pointer PMID 11269669 L-Carnitine laboratory index [PMID: 11269669] National Science Labs indexing note for PMID 11269669: review the PubMed methods, models, and limitations before citing